{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:08:02Z","timestamp":1793747282350,"version":"4.6.1"},"reference-count":30,"publisher":"Korean College of Neuropsychopharmacology","issue":"2","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.cpn.or.kr"],"crossmark-restriction":true},"short-container-title":["Clin Psychopharmacol Neurosci"],"published-print":{"date-parts":[[2023,5,30]]},"DOI":"10.9758\/cpn.2023.21.2.215","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T14:01:57Z","timestamp":1682776917000},"page":"215-221","update-policy":"https:\/\/doi.org\/10.9758\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Sublingual Dexmedetomidine for the Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder"],"prefix":"10.9758","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-4698","authenticated-orcid":false,"given":"Colin M.","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Behavioral Health, Phoenix Indian Medical Center, Indian Health Service, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2941-5224","authenticated-orcid":false,"given":"Morgan","family":"Santalucia","sequence":"additional","affiliation":[{"name":"Doctor of Pharmacy Program, Campbell University College of Pharmacy and Health Sciences, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8373-9916","authenticated-orcid":false,"given":"Hannah","family":"Bunn","sequence":"additional","affiliation":[{"name":"Doctor of Pharmacy Program, Campbell University College of Pharmacy and Health Sciences, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6904-2466","authenticated-orcid":false,"given":"Andrew","family":"Muzyk","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Campbell University College of Pharmacy and Health Sciences, Buies Creek, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4713","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1745017901612010075"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2011.9.6865"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2004.tb01434.x"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X187900"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200511001-00001"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2015.1132007"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_22_22"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.12138"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2011.9.6866"},{"key":"ref10","unstructured":"Wood B<italic>. Clinically significant acute agitation: consensus update. US Pharm 2010;35:HS-9-HS-15<\/italic>."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.04.013"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2021.11.334"},{"key":"ref13","unstructured":"BioXcel Therapeutics<italic>. IGALMI<sup>TM<\/sup> (dexmedetomidine) sublingual film, for sublingual or buccal use [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2022 [cited at 2022 Nov 27]. <a target=\"_blank\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215390s000lbl.pdf\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215390s000lbl.pdf<\/a><\/italic>."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000634"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0799"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22m14447"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02274-3"},{"key":"ref18","unstructured":"Alexza Pharmaceuticals<italic>. ADASUVE<sup>TM<\/sup> (loxapine) inhalation powder, for oral inhalation use [Internet]. Silver Spring (MD): Food and Drug Administration; 2012 [cited at 2022 Nov 27]. <a target=\"_blank\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022549s000lbl.pdf\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022549s000lbl.pdf<\/a><\/italic>."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2535"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2015.12.28763"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.7.717"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6152"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S343211"},{"key":"ref24","unstructured":"Hospira<italic>. Precedex (dexmedetomidine hydrochloride) label [Internet]. Silver Spring (MD): Food and Drug Administration; 2013 [cited at 2022 Nov 27]. <a target=\"_blank\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021038s021lbl.pdf\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021038s021lbl.pdf<\/a><\/italic>."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/635737"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P575"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.11080194"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.20cr02899"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.21313"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.21313"}],"container-title":["Clinical Psychopharmacology and Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2023\/021\/cpn021-02-01.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2023\/021\/cpn021-02-01.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T05:47:15Z","timestamp":1683784035000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2023.21.2.215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5,30]]}},"alternative-id":["10.9758\/cpn.2023.21.2.215"],"URL":"https:\/\/doi.org\/10.9758\/cpn.2023.21.2.215","relation":{},"ISSN":["1738-1088","2093-4327"],"issn-type":[{"value":"1738-1088","type":"print"},{"value":"2093-4327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2023.21.2.215","URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2023.21.2.215","name":"the_journal","label":"Clin Psychopharmacol Neurosci","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2023-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2023 The","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}